Kainos Medicine Inc Asset Resilience Ratio

Latest as of March 2025: 48.13%

Kainos Medicine Inc asset resilience ratio. Kainos Medicine Inc (284620) has an Asset Resilience Ratio of 48.13% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Kainos Medicine Inc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Liquid Assets

₩6.43 Billion

≈ $4.36 Million USD Cash + Short-term Investments

Total Assets

₩13.36 Billion

≈ $9.06 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Kainos Medicine Inc (2017–2024)

Asset resilience ratio of Kainos Medicine Inc from 2017 to 2024. This chart shows how Kainos Medicine Inc's Asset Resilience Ratio has changed over time. Read Kainos Medicine Inc (284620) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Kainos Medicine Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 284620 total asset value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩6.43 Billion	48.13%
Short-term Investments	₩0.00	0%
Total Liquid Assets	₩6.43 Billion	48.13%

Asset Resilience Insights

Very High Liquidity: Kainos Medicine Inc maintains exceptional liquid asset reserves at 48.13% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Kainos Medicine Inc Industry Peers by Asset Resilience Ratio

Compare Kainos Medicine Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Hyloris Developmentsen Sa BR:HYL	Biotechnology	1.36%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Oruka Therapeutics, Inc. NASDAQ:ORKA	Biotechnology	53.11%
Gempharmatech Co. Ltd. A SHG:688046	Biotechnology	23.95%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	74.48%
Inventiva S.A PA:IVA	Biotechnology	52.73%
Sunmax Biotechnology Co Ltd TWO:4728	Biotechnology	10.53%
Guangdong VTR Bio-Tech Co Ltd SHE:300381	Biotechnology	4.98%

Kainos Medicine Inc Asset Resilience Ratio by Year (2017–2024)

Kainos Medicine Inc asset resilience ratio by year from 2017 to 2024. The table below shows the annual Asset Resilience Ratio data for Kainos Medicine Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	35.69%	₩3.83 Billion ≈ $2.60 Million	₩10.74 Billion ≈ $7.28 Million	-42.16pp
2023-12-31	77.85%	₩16.34 Billion ≈ $11.07 Million	₩20.99 Billion ≈ $14.22 Million	+1.02pp
2022-12-31	76.83%	₩29.95 Billion ≈ $20.30 Million	₩38.98 Billion ≈ $26.42 Million	-4.75pp
2021-12-31	81.59%	₩34.23 Billion ≈ $23.20 Million	₩41.96 Billion ≈ $28.43 Million	-4.13pp
2020-12-31	85.72%	₩29.81 Billion ≈ $20.20 Million	₩34.78 Billion ≈ $23.57 Million	-13.35pp
2019-12-31	99.07%	₩10.60 Billion ≈ $7.18 Million	₩10.70 Billion ≈ $7.25 Million	-0.06pp
2018-12-31	99.12%	₩10.51 Billion ≈ $7.12 Million	₩10.60 Billion ≈ $7.18 Million	-0.87pp
2017-12-31	100.00%	₩1.69 Billion ≈ $1.15 Million	₩1.69 Billion ≈ $1.15 Million	--

pp = percentage points

About Kainos Medicine Inc

KQ:284620 Korea Biotechnology

Market Cap

$24.10 Million

₩35.56 Billion KRW

Market Cap Rank

#24355 Global

#1734 in Korea

Share Price

₩1087.00

Change (1 day)

+0.00%

52-Week Range

₩1087.00 - ₩1087.00

All Time High

₩28151.21